Gene-Disorder Association · Article
Gene
ESR1 Estrogen Receptor 1
×
First reported
1990
Supporting publications
114
Manually curated Approved treatment annotated
Association Review
In brief The association between ESR1 (Estrogen Receptor 1) and Breast Cancer is well established and manually curated, with its 4 contributing sources — 2 of them expert-curated — recording a known molecular basis.
Sources
4
Clinical variants
5
Symptoms
4
Compounds
36
Trials
3,016 of 9,212 via ESR1 compounds
Publications
114
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 4 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
3 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Breast Cancer
The disorder 23 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features 1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
ClinVar and variant evidence
Genetic basis 5 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
07
Population genetics
GWAS signals 6 GWAS phenotypes
Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.
Request access
08
Genomic context
Regulatory context 5 regulatory elements
GeneHancer regulatory elements for the pair, with coordinates, score, element type and supporting literature.
Request access
09
Mechanism overlap
Shared mechanisms 2 shared pathways
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
10
Interventions
Therapeutics 36 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
11
Human studies
Clinical trials 9,212 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
114 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
13
Provenance
References & sources 31 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access